$20.17
-1.19-5.57%
At Close: -
$20.17
00.00%
After Hours: Sep 20, 4:39 PM EDT
15 minutes delayed
Comments
Loading...
Rocket Pharmaceuticals (NASDAQ:RCKT) Stock, Earnings Estimates, EPS, And Revenue
Rocket Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 4
EPS Estimate
$-0.760
Quarterly Revenue Estimate
$810K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Rocket Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Rocket Pharmaceuticals (RCKT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-05 | $-0.74 | $-0.72 | -2.78 % |
| Mar 2024 | 2024-05-06 | $-0.66 | $-0.69 | 4.35 % |
| Dec 2023 | 2024-02-26 | $-0.64 | $-0.79 | 19.0 % |
| Sep 2023 | 2023-11-06 | $-0.75 | $-0.81 | 7.41 % |
Rocket Pharmaceuticals (RCKT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Rocket Pharmaceuticals (NASDAQ:RCKT) reporting earnings?
Rocket Pharmaceuticals (RCKT) is scheduled to report earnings on November 4, 2024. The last reported earnings were for reported on August 5, 2024 for Q2.
What were the latest earnings per share (EPS) for Rocket Pharmaceuticals (NASDAQ:RCKT)?
The Actual EPS was $-0.74, which missed the estimate of $-0.72.
What were Rocket Pharmaceuticals’s (NASDAQ:RCKT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.